Notice2024-29646
Solicitation of Nominations for Appointment to the Clinical Laboratory Improvement Advisory Committee
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 17, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), is seeking nominations for membership on the Clinical Laboratory Improvement Advisory Committee (CLIAC). CLIAC, consisting of up to 20 members including the Chair, represents a diverse membership across laboratory specialties, professional roles (laboratory management, technical specialists, physicians, nurses), and practice settings (academic, clinical, public health), and includes a consumer representative.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 242 (Tuesday, December 17, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 242 (Tuesday, December 17, 2024)]
[Notices]
[Page 102148]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-29646]
[[Page 102148]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Clinical
Laboratory Improvement Advisory Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), within the Department
of Health and Human Services (HHS), is seeking nominations for
membership on the Clinical Laboratory Improvement Advisory Committee
(CLIAC). CLIAC, consisting of up to 20 members including the Chair,
represents a diverse membership across laboratory specialties,
professional roles (laboratory management, technical specialists,
physicians, nurses), and practice settings (academic, clinical, public
health), and includes a consumer representative.
DATES: Nominations for membership on CLIAC must be received no later
than July 1, 2025. Packages received after this time will not be
considered for the current membership cycle.
ADDRESSES: All nominations should be emailed to <a href="/cdn-cgi/l/email-protection#13505f5a5250537077703d747c65"><span class="__cf_email__" data-cfemail="73303f3a3230331017105d141c05">[email protected]</span></a>.
FOR FURTHER INFORMATION CONTACT: Heather Stang, M.S., Senior Advisor
for Clinical Laboratories, Division of Laboratory Systems, Office of
Laboratory Systems and Response, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, Mailstop H24-2, Atlanta, Georgia
30329-4027. Telephone: (404) 498-2769; Email: <a href="/cdn-cgi/l/email-protection#0e465d7a6f60694e6d6a6d20696178"><span class="__cf_email__" data-cfemail="753d2601141b12351611165b121a03">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Nominations are sought for individuals who
have the expertise and qualifications necessary to contribute to the
accomplishment of the objectives of the Clinical Laboratory Improvement
Advisory Committee (CLIAC). Nominees will be selected based on
expertise in the fields of microbiology (including bacteriology,
mycobacteriology, mycology, parasitology, and virology), immunology
(including histocompatibility), chemistry, hematology, pathology
(including histopathology and cytology), or genetic testing (including
cytogenetics); from representatives in the fields of medical
technology, bioinformatics, public health, and clinical practice; and
from consumer representatives. Selection of members is based on
candidates' qualifications to contribute to the accomplishment of CLIAC
objectives (<a href="https://www.cdc.gov/cliac/php/about/index.html">https://www.cdc.gov/cliac/php/about/index.html</a>). Members
may be invited to serve up to four-year terms.
Department of Health and Human Services (HHS) policy stipulates
that committee membership be balanced in terms of points of view
represented and the committee's function. Appointments shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV status, disability, and
cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens and cannot be full-time employees of the U.S. Government.
Current participation on Federal workgroups or prior experience serving
on a Federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships. Committee
members are Special Government Employees, requiring the filing of
financial disclosure reports at the beginning of and annually during
their terms. The Centers for Disease Control and Prevention (CDC)
reviews potential candidates for CLIAC membership each year and
provides a slate of nominees for consideration to the Secretary of HHS
for final selection. HHS notifies selected candidates of their
appointment near the start of the term in July or as soon as the HHS
selection process is completed. Note that the need for different
expertise varies from year to year and a candidate who is not selected
in one year may be reconsidered in a subsequent year.
Candidates should submit the following items:
<bullet> Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address).
<bullet> At least one letter of recommendation from person(s) not
employed by HHS. Candidates may submit letter(s) from current HHS
employees if they wish, but at least one letter must be submitted by a
person not employed by an HHS agency (e.g., CDC, National Institutes of
Health, Food and Drug Administration).
Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-29646 Filed 12-16-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on December 17, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.